MedPath

UNIVERSITY OF SOUTH FLORIDA

UNIVERSITY OF SOUTH FLORIDA logo
🇺🇸United States
Ownership
Private
Established
1956-01-01
Employees
10K
Market Cap
-
Website
http://www.usf.edu

TrialNet Pathway to Prevention of T1D

Recruiting
Conditions
Diabetes Mellitus, Type 1
First Posted Date
2004-11-22
Last Posted Date
2025-04-15
Lead Sponsor
University of South Florida
Target Recruit Count
75000
Registration Number
NCT00097292
Locations
🇨🇦

The Hospital for Sick Children, Toronto, Ontario, Canada

🇺🇸

Baylor College of Medicine, Houston, Texas, United States

🇺🇸

Benaroya Research Institute, Seattle, Washington, United States

and more 19 locations

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Phase 2
Terminated
Conditions
Breast Cancer
Hormone Changes
Drug Toxicity
Interventions
First Posted Date
2004-09-08
Last Posted Date
2021-01-28
Lead Sponsor
University of South Florida
Target Recruit Count
49
Registration Number
NCT00090844
Locations
🇺🇸

MBCCOP - JHS Hospital of Cook County, Chicago, Illinois, United States

🇺🇸

MBCCOP - Medical College of Georgia Cancer Center, Augusta, Georgia, United States

🇺🇸

CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States

and more 6 locations

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

Not Applicable
Conditions
Pancreatic Cancer
First Posted Date
2004-03-10
Last Posted Date
2013-12-04
Lead Sponsor
University of South Florida
Registration Number
NCT00079365
Locations
🇺🇸

USF Physician's Group, Tampa, Florida, United States

Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

Phase 2
Terminated
Conditions
Neurotoxicity
Unspecified Childhood Solid Tumor, Protocol Specific
Depression
Interventions
Drug: Adderall-XR®
First Posted Date
2003-10-07
Last Posted Date
2014-02-03
Lead Sponsor
University of South Florida
Target Recruit Count
12
Registration Number
NCT00069927
Locations
🇺🇸

St. Joseph's Children's Hospital of Tampa, Tampa, Florida, United States

🇺🇸

CHRISTUS Santa Rosa Children's Hospital, San Antonio, Texas, United States

🇺🇸

University of Florida Shands Cancer Center, Gainesville, Florida, United States

and more 6 locations

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Phase 2
Completed
Conditions
Brain Tumor
Central Nervous System Tumors
Myelodysplastic Syndromes
Unspecified Childhood Solid Tumor, Protocol Specific
Myelodysplastic/Myeloproliferative Diseases
Cachexia
Leukemia
Lymphoma
Interventions
First Posted Date
2003-08-07
Last Posted Date
2014-02-03
Lead Sponsor
University of South Florida
Target Recruit Count
70
Registration Number
NCT00066248
Locations
🇺🇸

Kaplan Cancer Center at St. Mary's Medical Center, West Palm Beach, Florida, United States

🇺🇸

Children's Hospital and Regional Medical Center - Seattle, Seattle, Washington, United States

🇺🇸

University of Florida Shands Cancer Center, Gainesville, Florida, United States

and more 40 locations

Stress Management Training in Patients Undergoing Radiation Therapy for Cancer

Not Applicable
Completed
Conditions
Anxiety Disorder
Depression
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2003-04-09
Last Posted Date
2013-05-30
Lead Sponsor
University of South Florida
Registration Number
NCT00057733
Locations
🇺🇸

CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States

🇺🇸

CCOP - Western Regional, Arizona, Phoenix, Arizona, United States

🇺🇸

Cancer Care and Research Pavilion at St. Joseph's/Candler, Savannah, Georgia, United States

and more 9 locations
© Copyright 2025. All Rights Reserved by MedPath